FDA Approves Neurocrine Biosciences' Parkinson's Drug

FDA Approves Neurocrine Biosciences' Parkinson's Drug

Submitted by admin on April 27, 2020 - 7:35pm
Source: 
Motley Fool
News Tags: 
Neurocrine
FDA
Ongentys
Parkinson's Disease
Headline: 
FDA Approves Neurocrine Biosciences' Parkinson's Drug
snippet: 

Neurocrine Biosciences (NASDAQ:NBIX) announced Monday that the Food and Drug Administration (FDA) has approved Ongentys (opicapone), a daily pill for Parkinson's disease.

Do Not Allow Advertisers to Use My Personal information